```html

Xanthopsia of Night Vision: What It Is, Why It Happens, and How to Manage It

What is Xanthopsia of Night Vision?

Xanthopsia is a visual disturbance in which objects appear tinged with a yellow hue. When this discoloration is most noticeable in low‑light or nighttime settings, it is referred to as xanthopsia of night vision. The condition does not usually affect visual acuity (sharpness) but can alter color perception, contrast, and depth perception, making activities such as driving at night, walking in dimly lit areas, or reading instrument panels more challenging.

The term comes from the Greek words “xanthos” (yellow) and “opsis” (vision). It is a type of chromatic aberration and is considered a symptom rather than a disease itself. Its presence often signals an underlying ocular, neurological, or systemic issue that requires evaluation.

Common Causes

Many different conditions can produce yellow‑tinted night vision. Below are the most frequently reported causes, grouped by category.

• Medication‑induced toxicity
  • Digitalis (digoxin) – classic cause of yellow vision.
  • Quinine and chloroquine derivatives.
  • Phenothiazines (e.g., chlorpromazine).
• Lens changes
  • Cataract formation, especially nuclear sclerosis, which yellow‑filters incoming light.
• Retinal disorders
  • Retinitis pigmentosa – loss of rods can unmask yellow‑sensitive cones.
  • Age‑related macular degeneration (dry type) – alters cone function.
• Neurological disease
  • Horner’s syndrome – sympathetically mediated changes in pupil size may affect color perception.
  • Multiple sclerosis lesions in the optic pathway.
• Metabolic and systemic conditions
  • Liver disease (jaundice) – excess bilirubin can accumulate in ocular tissues.
  • Diabetes mellitus – fluctuating glucose may transiently change lens transparency.
• Vitamin deficiencies
  • Vitamin A deficiency – impairs rod function, leading to altered night‑color perception.
• Eye trauma or surgery
  • Intra‑ocular lens (IOL) implantation with yellow‑tint filters.
  • Posterior capsular opacification (PCO) after cataract surgery.
• Genetic disorders
  • Congenital stationary night blindness (CSNB) – abnormal signaling in rod pathways.
• Environmental exposure
  • Chronic exposure to bright blue light can cause “blue‑light hazard,” leading the eye to adapt by preferentially filtering yellow wavelengths.

Associated Symptoms

Patients with xanthopsia of night vision often notice other visual or systemic clues that help narrow the cause.

• Glare or halos around lights, especially at night.
• Reduced contrast sensitivity (difficulty distinguishing gray objects on a gray background).
• Generalized blurriness or haziness that improves with bright daylight.
• Photopsia (flashing lights) or visual snow.
• Eye discomfort, dryness, or a sensation of “grittiness.”
• Systemic signs such as fatigue, jaundice, or medication side‑effects (e.g., nausea with digoxin).
• Difficulty adapting from bright to dark environments (delayed dark adaptation).

When to See a Doctor

Because yellow‑tinged night vision can indicate serious underlying pathology, prompt medical attention is recommended when any of the following occur:

• Sudden onset of the symptom, especially if it follows a head injury, new medication, or systemic illness.
• Progressive worsening over days to weeks.
• Accompanying vision loss, double vision, or a black spot in the visual field.
• New or worsening glare while driving at night.
• Associated neurological signs (headache, weakness, numbness, speech changes).
• Signs of systemic disease (yellowing of skin or eyes, unexplained weight loss, fever).

For any of the above, schedule an appointment with an eye‑care professional (optometrist or ophthalmologist) or your primary care physician within 24–48 hours.

Diagnosis

Evaluation typically proceeds in three stages: history, examination, and targeted testing.

1. Detailed History

• Onset, duration, and pattern of the yellow tint.
• Medication list (including over‑the‑counter and herbal supplements).
• Recent surgeries, injuries, or exposures.
• Systemic illnesses (liver disease, diabetes, autoimmune disorders).
• Family history of retinal or genetic eye disease.

2. Clinical Eye Examination

• Visual acuity testing – confirms whether central vision is intact.
• Color vision testing – Ishihara plates or Farnsworth D‑15 to detect color‑processing deficits.
• Slit‑lamp biomicroscopy – evaluates the cornea, lens, and anterior chamber for cataract or deposits.
• Fundus examination – dilated retinal inspection for pigmentary changes, optic nerve edema, or vascular lesions.
• Dark‑adaptation testing – measures the time needed for the eye to adjust to low light.

3. Ancillary Tests

• Optical coherence tomography (OCT) – cross‑sectional imaging of retina and macula.
• Electroretinography (ERG) – assesses rod and cone function, useful for inherited retinal disorders.
• Visual field testing – identifies peripheral deficits that may accompany night‑vision changes.
• Blood work – liver function panel, serum bilirubin, fasting glucose, vitamin A levels, and digoxin serum concentration when medication‑related.
• Imaging – MRI of brain/orbits if neurological causes are suspected.

Treatment Options

Treatment is directed at the underlying cause; there is no “cure” for the symptom alone.

Medication‑related Causes

• Discontinue or replace the offending drug (e.g., switch from digoxin to an alternative heart‑failure medication) under physician supervision.
• Adjust dosage if toxicity is dose‑dependent.
• Monitor serum drug levels until visual symptoms resolve (often within days to weeks).

Lens and Cataract Issues

• Prescription of anti‑yellowing intra‑ocular lenses (IOLs) during cataract surgery.
• Early cataract extraction if visual impairment interferes with daily activities.

Retinal and Degenerative Disorders

• Vitamin A supplementation for deficiency (generally 10,000 IU retinol daily, monitored by a physician).
• Low‑vision aides – night‑vision glasses with anti‑glare coating, high‑contrast lenses, or electronic magnifiers.
• Disease‑specific therapies: anti‑VEGF injections for neovascular AMD, gene‑therapy clinical trials for certain inherited retinal dystrophies.

Systemic Conditions

• Treat underlying liver disease (antivirals for hepatitis, lifestyle changes for alcoholic liver disease).
• Optimize diabetes control (HbA1c < 7 %) to prevent further ocular complications.
• Address vitamin deficiencies with oral supplementation and dietary counseling.

Supportive and Home Measures

• Improve ambient lighting: use full‑spectrum bulbs and avoid overly bright headlights.
• Wear polarized sunglasses during the day to reduce glare, and consider yellow‑filter glasses at night only if they improve contrast (personal trial recommended).
• Maintain a regular sleep schedule; good dark‑adaptation is compromised by irregular circadian rhythms.
• Stay hydrated and limit alcohol, which can exacerbate cataract formation and liver dysfunction.

Prevention Tips

While not every cause is preventable, many risk factors are modifiable.

• Medication vigilance: Review all prescriptions annually with your doctor or pharmacist; ask about visual side‑effects.
• Protect your eyes from UV and blue light: Wear sunglasses with UV‑400 protection; use screen filters on computers and smartphones.
• Healthy diet: Include leafy greens, carrots, and fish rich in omega‑3 fatty acids to support retinal health.
• Regular eye exams: At least every 1–2 years, or more frequently if you have diabetes, a family history of retinal disease, or take high‑risk medications.
• Limit alcohol and smoking: Both accelerate cataract formation and vascular damage to the retina.
• Control systemic diseases: Keep blood pressure, cholesterol, and blood sugar within target ranges.
• Promptly address eye injuries: Seek care immediately after any trauma to the eye.

Emergency Warning Signs

Key Take‑aways

Xanthopsia of night vision is a yellow‑tinged visual disturbance most noticeable in low‑light conditions. It is typically a symptom of an underlying ophthalmic, neurological, or systemic problem. By recognizing the possible causes, associated symptoms, and red‑flag warnings, patients can seek timely evaluation and treatment. Early diagnosis—whether it involves adjusting medication, treating liver disease, or addressing cataract formation—can often reverse the discoloration and prevent permanent vision loss.

References:

1. Mayo Clinic. “Digitalis toxicity.” Accessed March 2024.
2. National Eye Institute (NEI). “Cataract.” Updated 2023.
3. American Academy of Ophthalmology. “Retinitis pigmentosa.” Clinical practice guideline, 2022.
4. Centers for Disease Control and Prevention. “Vitamin A deficiency.” 2023.
5. World Health Organization. “Global prevalence of liver disease.” 2022 report.
6. Cleveland Clinic. “Night vision problems: causes and treatments.” 2024.

```